|
2024
|
Invention
|
Novel crispr dna and rna targeting enzymes and systems.
The disclosure describes novel systems, ... |
|
|
Invention
|
Reverse transcription-mediated gene editing systems and uses thereof. A gene editing system compr... |
|
|
Invention
|
Crispr nuclease polypeptides and gene editing systems comprising such. Engineered CRISPR nuclease... |
|
|
Invention
|
Gene editing systems targeting pcsk9 and uses thereof. PCSK9PCSK9PCSK9 gene in a cell. |
|
|
Invention
|
Novel crispr-associated transposon systems and components.
The disclosure describes novel system... |
|
|
Invention
|
Crispr nuclease polypeptides and gene editing systems comprising such. A nuclease polypeptide suc... |
|
|
Invention
|
Crispr nuclease polypeptides and gene editing systems comprising such. CRISPR nuclease polypeptid... |
|
|
Invention
|
Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript.
A method ... |
|
|
Invention
|
Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript. A method f... |
|
|
Invention
|
Gene editing systems comprising type v crispr nuclease and engineered guide rna. A gene editing s... |
|
2023
|
Invention
|
Reverse transcriptase-mediated genetic editing of transthyretin (ttr) and uses thereof. A system ... |
|
|
Invention
|
Crispr dna targeting enzymes and systems.
The disclosure describes novel systems, methods, and c... |
|
|
P/S
|
Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases... |
|
|
P/S
|
Pharmaceutical preparations and therapeutic pharmaceuticals
for the treatment of genetic disease... |
|
|
Invention
|
Compositions comprising a variant nuclease and uses thereof. The present invention relates to var... |
|
|
Invention
|
Compositions comprising a variant polypeptide and uses thereof. The present invention relates to ... |
|
|
Invention
|
Novel crispr-associated systems and components.
The disclosure describes novel systems, methods,... |
|
|
Invention
|
Compositions comprising an rna guide targeting cd38 and uses thereof. The present invention relat... |
|
2022
|
Invention
|
Compositions comprising a variant cas12i4 polypeptide and uses thereof. The present invention rel... |
|
|
Invention
|
Crispr dna targeting enzymes and systems. The disclosure describes novel systems, methods, and co... |
|
|
Invention
|
Gene editing systems targeting hydroxyacid oxidase 1 (hao1) and lactate dehydrogenase a (ldha). T... |
|
|
Invention
|
Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses th... |
|
|
Invention
|
Compositions comprising a cas12i polypeptide and uses thereof.
The present invention relates to ... |
|
|
Invention
|
Compositions comprising a crispr nuclease and uses thereof.
The present disclosure relates to va... |
|
|
Invention
|
Cells modified by a cas12i polypeptide.
The present disclosure relates to cells (e.g., T cells) ... |
|
|
Invention
|
Compositions comprising a variant cas12i3 polypeptide and uses thereof.
The present invention re... |
|
|
Invention
|
Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereof.
A sy... |
|
|
Invention
|
Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereof.
A s... |
|
|
Invention
|
Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses ther... |
|
|
Invention
|
Gene editing systems comprising a crispr nuclease and uses thereof.
A gene editing system compri... |
|
|
Invention
|
Compositions comprising a variant polypeptide and uses thereof.
The present invention relates to... |
|
|
Invention
|
Compositions comprising a variant cas12i4 polypeptide and uses thereof.
The present invention re... |
|
|
Invention
|
Crispr-associated transposon systems and methods of using same.
The present disclosure relates t... |
|
|
Invention
|
Compositions comprising a nuclease and uses thereof.
The present invention relates to nucleases ... |
|
|
Invention
|
Cas12i2 fusion molecules and uses thereof.
The disclosure describes Cas12i2 fusion proteins, met... |
|
|
Invention
|
Compositions comprising a variant crispr nuclease polypeptide and uses thereof.
The present inve... |
|
2021
|
Invention
|
Compositions comprising an rna guide targeting trac and uses thereof.
The present invention rela... |
|
|
Invention
|
Compositions comprising an rna guide targeting bcl11a and uses thereof.
The present invention re... |
|
|
Invention
|
Compositions comprising an rna guide targeting pdcd1 and uses thereof.
The present invention rel... |
|
|
Invention
|
Compositions comprising an rna guide targeting b2m and uses thereof.
The present invention relat... |
|
|
Invention
|
Compositions comprising a nuclease and uses thereof.
The present invention relates nucleases, pr... |
|
|
Invention
|
Cells modified by a cas12i polypeptide.
The present disclosure relates to cells modified by a Ca... |
|
|
Invention
|
Compositions comprising a cas12i2 polypeptide and uses thereof.
The present invention relates to... |
|
|
Invention
|
Compositions comprising a cas12i2 variant polypeptide and uses thereof.
The present invention re... |
|
2020
|
P/S
|
Protein and enzyme discovery research for industrial applications; research and development in th... |
|
|
P/S
|
Protein and enzyme discovery research for industrial
applications; research and development of t... |
|
|
P/S
|
Protein and enzyme discovery research for non-medical industrial applications; non-medical indust... |
|
2019
|
Invention
|
Crispr dna and rna targeting enzymes and systems. The disclosure describes novel systems, methods... |
|
2018
|
P/S
|
Peptide, protein, and enzyme discovery research for therapeutic, diagnostic, and industrial appli... |
|
2017
|
P/S
|
Protein and enzyme discovery research for therapeutic, diagnostic, and industrial applications; r... |
